Bone marrow-derived mesenchymal stem cells for treatment of liver cirrhosis
The aim of this study is to determine the efficacy of autologous bone marrow-derived mesenchymal stem cell (BM-MSCs) transplantation via the hepatic artery, in treating liver cirrhosis.
Read More
No additional information regarding the therapeutic cells was provided by the sponsor.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for treatment of liver cirrhosis